oncology management

Drug Combination Reduces Adverse Events and Need for Dose Reductions

06/02/2016

JCP Editors

The addition of plinabulin to non-small cell lung cancer (NSCLC) treatment with docetaxel may reduce the frequency of adverse events and help prevent dose reductions due to toxicity, according to an abstract at the...

The...

06/02/2016

Journal of Clinical Pathways

Research in Review

Review of EGFR Mutation-Positive NSCLC Drugs Identifies Optimal Treatments

06/02/2016

JCP Editors

A review of treatments for non-small cell lung cancer (NSCLC) that is epidermal growth factor receptor mutation positive (EGFR M+) has identified which therapies are the most effective at managing disease symptoms...

A...

06/02/2016

Journal of Clinical Pathways

Transplant Still Preferred Treatment Choice in Young Patients With Myeloma

05/31/2016

JCP Editors

Autologous stem cell transplantation (ASCT) is still the preferred treatment of choice for patients under the age of 65 years with newly diagnosed multiple myeloma (NDMM), according to early results from a phase 3...

...

05/31/2016

Journal of Clinical Pathways

Research in Review

FDA Approval Process Flawed for Cancer Drugs

05/30/2016

JCP Editors

A study published in Mayo Clinic Proceedings has called into question how the Food and Drug Administration (FDA) uses surrogate endpoints in approvals for certain cancer medications. Surrogate endpoints are measures...

A...

05/30/2016

Journal of Clinical Pathways

Research in Review

Nutritional Status an Indicator of Survival in Patients With Esophageal Cancer

05/25/2016

JCP Editors

Nutritional status may be a prominent indicator of survival in elderly patients with esophageal cancer, claims a recently published study. Esophageal cancer is one of the leading causes of cancer-related death...

...

05/25/2016

Journal of Clinical Pathways

Research in Review

Weight Gain a Sign of Successful Treatment in Patients With NSCLC

05/24/2016

JCP Editors

Weight gain may be an indicator of successful treatment for patients with non-small cell lung cancer (NSCLC), according to findings from a recently published article. Past studies have linked unintentional weigh...

Weight...

05/24/2016

Journal of Clinical Pathways

Research in Review

Costs of Adverse Events Quantified for Breast Cancer Patients

05/24/2016

JCP Editors

Adverse events (AEs) may be a driver of high health care costs in patients with metastatic breast cancer treated with systemic therapy, according to a new study. AEs are a serious concern for patients and providers,...

...

05/24/2016

Journal of Clinical Pathways

Quality Measures for NSCLC Significantly Improve Survival

05/20/2016

JCP Editors

Including certain quality measures as a part of care for patients with non-small cell lung cancer (NSCLC) who undergo surgery can significantly improve survival, according to results presented at the American...

...

05/20/2016

Journal of Clinical Pathways

Research in Review

Algorithm Can Help Reduce Delays in Lung Cancer Evaluation

05/19/2016

JCP Editors

An algorithm designed to identify patients with a risk of cancer in need of follow-up may help to reduce delays in the diagnostic evaluation of abnormal chest imaging results, according to a recent...

An...

05/19/2016

Journal of Clinical Pathways

Research in Review

Pancreatic Cancer Resources Available Online Inaccurate and Difficult to Read

05/13/2016

JCP Editors

Online materials about pancreatic cancer may lack accurate information about alternative therapy and be too complicated to benefit patients with the disease, claims a recent study. The readability and accuracy of...

Online...

05/13/2016

Journal of Clinical Pathways